DBV Technologies S.A.
DBVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesDBVTF
Holders of 5% or more of DBVT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of DBV Technologies S.A., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 13D/A | 9.99%25.6M shares | −7.11 ppfrom 17.10% | Jun 13, 20223 filings | Jan 14, 2026 | SEC |
| Suvretta Capital Management, LLC | 13G | 9.90%15.2M shares | New | Apr 11, 20251 filing | Apr 11, 2025 | SEC |
| Janus Henderson Group PLC | 13G/A | 8.80%20.5M shares | +6.20 ppfrom 2.60% | Dec 8, 20253 filings | Jan 8, 2026 | SEC |
| Adage Capital Management, L.P. | 13G/A | 7.31%22.3M shares | −2.68 ppfrom 9.99% | Aug 12, 20252 filings | May 13, 2026 | SEC |
| Invus Global Management, LLC | 13G/A | 6.50%19.3M shares | +0.30 ppfrom 6.20% | Oct 14, 20253 filings | May 5, 2026 | SEC |
| MPM Oncology Impact Management LP | 13G/A | 6.20%18.3M shares | −2.60 ppfrom 8.80% | Feb 17, 20263 filings | Aug 14, 2026 | SEC |
| Ra Capital Management, L.P. | 13G | 5.80%18.3M shares | New | Aug 6, 20261 filing | Aug 6, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
46 Schedule 13D and 13G filings on DBV Technologies S.A., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20264:03 PM ET | MPM Oncology Impact Management LP | 13G/A | 6.20%18.3M shares | −2.60 ppfrom 8.80% | Jun 30, 2026 | SEC |
| Aug 6, 20265:50 PM ET | Ra Capital Management, L.P.and 3 others | 13G | 5.80%18.3M shares | New | Jul 30, 2026 | SEC |
| May 15, 20264:09 PM ET | MPM Oncology Impact Management LP | 13G/A | 8.80%26.1M shares | −1.10 ppfrom 9.90% | Mar 31, 2026 | SEC |
| May 13, 20269:03 AM ET | Adage Capital Management, L.P.and 2 others | 13G/A | 7.31%22.3M shares | −2.68 ppfrom 9.99% | Mar 31, 2026 | SEC |
| May 13, 20267:00 AM ET | Artisan Partners Limited Partnershipand 3 others | 13G/A | 3.70%2.22M shares | −3.30 ppfrom 7.00%Below 5% | Mar 31, 2026 | SEC |
| May 12, 20269:44 PM ET | Vivo Opportunity Fund Holdings, L.P.and 3 others | 13G/A | 4.00%11.8M shares | −1.70 ppfrom 5.70%Below 5% | Mar 31, 2026 | SEC |
| May 5, 20269:57 AM ET | Invus Global Management, LLCand 7 others | 13G/A | 6.50%19.3M shares | +0.30 ppfrom 6.20% | Mar 31, 2026 | SEC |
| Feb 17, 20266:08 PM ET | Venrock Healthcare Capital Partners II, L.P.and 9 others | 13G/A | 0.00%0 shares | −8.20 ppfrom 8.20%Below 5% | Dec 31, 2025 | SEC |
| Feb 17, 20264:37 PM ET | Citadel Advisors LLCand 6 others | 13G/A | 3.50%8.15M shares | −2.90 ppfrom 6.40%Below 5% | Dec 31, 2025 | SEC |
| Feb 17, 20264:10 PM ET | MPM Oncology Impact Management LP | 13G | 9.90%24.6M shares | New | Dec 31, 2025 | SEC |
| Feb 13, 20266:11 PM ET | Vivo Opportunity Fund Holdings, L.P.and 3 others | 13G/A | 5.70%15.7M shares | −4.29 ppfrom 9.99% | Jan 12, 2026 | SEC |
| Feb 13, 202611:25 AM ET | Invus Global Management, LLCand 7 others | 13G/A | 6.20%14.4M shares | −1.60 ppfrom 7.80% | Dec 31, 2025 | SEC |
| Feb 3, 20262:00 PM ET | Artisan Partners Limited Partnershipand 3 others | 13G | 7.00%3.31M shares | New | Dec 31, 2025 | SEC |
| Jan 14, 20265:36 PM ET | Baker Bros. Advisors LPand 3 others | 13D/A | 9.99%25.6M shares | −7.11 ppfrom 17.10% | Jan 12, 2026 | SEC |
| Jan 8, 202612:15 PM ET | Janus Henderson Group PLC | 13G/A | 8.80%20.5M shares | +6.20 ppfrom 2.60% | Dec 31, 2025 | SEC |
| Jan 7, 20264:01 PM ET | Bpifrance Participations SAand 5 others | 13D/A | 4.70%10.9M shares | −0.60 ppfrom 5.30%Below 5% | Jan 5, 2026 | SEC |
| Jan 5, 20264:02 PM ET | Bpifrance Participations SAand 5 others | 13D/A | 5.30%11.0M shares | −1.50 ppfrom 6.80% | Dec 31, 2025 | SEC |
| Dec 19, 20256:32 PM ET | Bpifrance Participations SAand 5 others | 13D/A | 6.80%14.1M shares | −2.60 ppfrom 9.40% | Dec 17, 2025 | SEC |
| Dec 12, 20251:06 PM ET | Janus Henderson Group PLC | 13G/A | 2.60%5.27M shares | −6.90 ppfrom 9.50%Below 5% | Nov 28, 2025 | SEC |
| Dec 8, 202511:44 AM ET | Janus Henderson Group PLC | 13G | 9.50%20.5M shares | New | Nov 28, 2025 | SEC |
| Nov 14, 20255:40 PM ET | Venrock Healthcare Capital Partners II, L.P.and 9 others | 13G/A | 8.20%11.9M shares | −1.60 ppfrom 9.80% | Sep 30, 2025 | SEC |
| Nov 4, 20254:14 PM ET | Bpifrance Participations SAand 5 others | 13D/A | 9.40%17.5M shares | −2.80 ppfrom 12.20% | Oct 31, 2025 | SEC |
| Oct 14, 20255:14 PM ET | Invus Global Management, LLCand 7 others | 13G | 7.80%11.5M shares | New | Oct 6, 2025 | SEC |
| Aug 14, 20256:01 PM ET | Venrock Healthcare Capital Partners II, L.P.and 9 others | 13G/A | 9.80%14.3M shares | – | Jun 30, 2025 | SEC |
| Aug 12, 20259:06 AM ET | Adage Capital Management, L.P.and 2 others | 13G | 9.99%14.6M shares | New | Jun 30, 2025 | SEC |
| Apr 14, 20256:57 PM ET | Citadel Advisors LLCand 6 others | 13G | 6.40%9.19M shares | New | Apr 7, 2025 | SEC |
| Apr 11, 20254:46 PM ET | Suvretta Capital Management, LLCand 2 others | 13G | 9.90%15.2M shares | New | Apr 7, 2025 | SEC |
| Apr 8, 20256:15 PM ET | Vivo Opportunity Fund Holdings, L.P.and 3 others | 13G | 9.99%20.4M shares | New | Apr 7, 2025 | SEC |
| Apr 7, 20254:50 PM ET | Bpifrance Participations SAand 5 others | 13D/A | 12.20%17.5M shares | – | Mar 27, 2025 | SEC |
| Mar 31, 20257:35 PM ET | Baker Bros. Advisors LPand 3 others | 13D/A | 17.10%23.5M shares | – | Mar 27, 2025 | SEC |
| Feb 14, 20254:25 PM ET | Braidwell LPand 3 others | 13G/A | 2.50%2.39M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 2024 | Braidwell LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Venrock Healthcare Capital Partners II, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Braidwell LP | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Venrock Healthcare Capital Partners II, L.P. | 13G/AOld format | – | – | – | SEC |
| Jun 23, 2022 | Venrock Healthcare Capital Partners II, L.P. | 13GOld format | – | New | – | SEC |
| Jun 16, 2022 | Bpifrance Participations SA | 13D/AOld format | – | – | – | SEC |
| Jun 13, 2022 | Baker Bros. Advisors LP | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Boxer Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Jun 10, 2021 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Boxer Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Perceptive Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Bpifrance Participations SA | 13D/AOld format | – | – | – | SEC |
| Jan 25, 2021 | Morgan Stanley | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell DBV Technologies S.A. shares.
No Form 144 notices for DBV Technologies S.A. are on file.